<--- Back to Details
First PageDocument Content
Spectrum Pharmaceuticals / Drug development / Ibritumomab tiuxetan / Triple-negative breast cancer
Date: 2016-06-03 11:22:57
Spectrum Pharmaceuticals
Drug development
Ibritumomab tiuxetan
Triple-negative breast cancer

MARKET SNAPSHOT Stock priceweek range Market capitalization Shares outstanding Institutional ownership

Add to Reading List

Source URL: www.casipharmaceuticals.com

Download Document from Source Website

File Size: 413,22 KB

Share Document on Facebook

Similar Documents

Microsoft Word - FINAL 10K2014-Cover Page final to print

Microsoft Word - FINAL 10K2014-Cover Page final to print

DocID: 1r76P - View Document

MARKET SNAPSHOT Stock priceweek range Market capitalization Shares outstanding Institutional ownership

MARKET SNAPSHOT Stock priceweek range Market capitalization Shares outstanding Institutional ownership

DocID: 1p2pn - View Document

Sunovion Pharmaceuticals Inc. 84 Waterford Drive, Marlborough, MATelNews Release Contact:

Sunovion Pharmaceuticals Inc. 84 Waterford Drive, Marlborough, MATelNews Release Contact:

DocID: 1geP9 - View Document

IPandYou_Bulletin_Antibiotics resistance

IPandYou_Bulletin_Antibiotics resistance

DocID: 12xRY - View Document

IPandYou_Bulletin_Antibiotics resistance

IPandYou_Bulletin_Antibiotics resistance

DocID: XGxl - View Document